This RMAT designation is based on data from 3 clinical studies demonstrating the potential benefit of AAV-GAD as a one-time treatment for Parkinson’s disease- RMAT designation ...

Lina Romero - In the current landscape, we are seeing an upward trend of attacks, and this is only continuing to rise. The way we’ve been approaching applications needs to change drastically to ...